AnaptysBio Inc (ANAB)
14.28
+0.31
(+2.22%)
USD |
NASDAQ |
Dec 24, 11:25
AnaptysBio Cash from Investing (Quarterly): 58.62M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -4.005B |
| SIGA Technologies Inc | -0.0224M |
| Candel Therapeutics Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.09M |
| Cash from Financing (Quarterly) | 71.23M |
| Free Cash Flow | -103.39M |
| Free Cash Flow Per Share (Quarterly) | -0.3504 |
| Free Cash Flow to Equity (Quarterly) | -10.12M |
| Free Cash Flow to Firm (Quarterly) | -0.036M |
| Free Cash Flow Yield | -26.42% |